Company news

Simulations Plus, Inc. news in 2026

Simulations Plus, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Simulations Plus Announces Funded Partnership with Global Pharmaceutical Company to Advance AI-Enabled QSP Model Development with Turin

October 8, 2026

Simulations Plus Announces Completion of Acquisition by Altaris

October 6, 2026

Simulations Plus Expands FDA Adoption of ADMET Predictor(R) with New Licenses for the Cosmetics Regulatory Science Branch

September 18, 2026

Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch

September 17, 2026

Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris

August 13, 2026

Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results

July 9, 2026

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

July 6, 2026

Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit

June 23, 2026

Simulations Plus to Be Acquired by Altaris For Approximately $375 Million

June 16, 2026

Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference

May 21, 2026

Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows

May 6, 2026

Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

April 21, 2026

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

April 20, 2026

Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results

April 8, 2026

Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date

March 26, 2026

Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling

March 25, 2026

Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD

March 3, 2026

Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

February 9, 2026

Simulations Plus to Participate in Upcoming Investor Conferences

February 3, 2026

Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day

January 21, 2026

Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

January 8, 2026

Calls in 2026

Decks in 2026